Skip to content
OpenCapital
Get started

BioLife Solutions BLFS Enterprise value

Enterprise value at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$222.48B+0.9%
Danaher logo
DanaherDHR
$148.16B-8.7%
Azenta logo
AzentaAZTA
$903.8M—
LeMaitre Vascular logo
LeMaitre VascularLMAT
$2.48B+31.6%
TEC
Bio-TechneTECH
$8.26B-13.6%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$370.65M+13.7%

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02—

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.25B+23.8%
P/S12.5×-0.4×

Profitability

See full
Gross margin66.9%—
Operating margin-16.7%—
Net margin-68.7%—
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0×0.0×
Current ratio7.3×+2.6×

Where this comes from

Calculated from BioLife Solutions’s reported figures.

$921.6Mmarket cap+$17.4Mtotal debt−$22.8Mcash and equivalents=$916.1M

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's enterprise value?
BioLife Solutions (BLFS) reported enterprise value of $916.1M in Q1 2026.
How has BioLife Solutions's enterprise value changed year-over-year?
BioLife Solutions's enterprise value decreased by 11.2% year-over-year, from $1.03B to $916.1M.
What is the long-term trend for BioLife Solutions's enterprise value?
Over 5 years (2020 to 2025), BioLife Solutions's enterprise value has grown at a -6.2% compound annual growth rate (CAGR), from $1.58B to $1.15B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.